Skip to main content
Log in

PMC vaccines: better meningitis control at acceptable cost

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. polyvalent meningococcal polysaccharide

Reference

  • Yaesoubi R, et al. The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study. PLOS Medicine : 24 Jan 2018. Available from: URL: https://doi.org/10.1371/journal.pmed.1002495

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

PMC vaccines: better meningitis control at acceptable cost. PharmacoEcon Outcomes News 796, 25 (2018). https://doi.org/10.1007/s40274-018-4699-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4699-3

Navigation